Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T05:58:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed description of a clinical trial for pembrolizumab in esophageal carcinoma, including its purpose, inclusion and exclusion criteria, and study identifiers. The only notable addition is a revision number update.
    Difference
    10%
    Check dated 2025-04-16T15:00:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T10:15:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:29:47.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.4%
    Check dated 2025-02-24T21:11:11.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.4%
    Check dated 2025-02-10T10:15:26.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.